Influenza viruses are among the most likely triggers of future pandemics. A research team has developed a method that can be used to study the interaction of viruses with host cells in unprecedented ...

Researchers from the University of São Paulo in Brazil have discovered that silver nanoparticles produced by a fungus called ...

Studies show how spike protein changes determine the risk of viral outbreaks, offering important insights for the future ...

The US Food and Drug Administration has approved CRISPR gene-edited pigs for human consumption. As MIT Technology Review ...

Altesa BioSciences today announced positive topline results from its Phase 2 placebo-controlled study examining the effects of vapendavir in COPD patients challenged with rhinovirus.  In this study, ...

Our lungs are constantly exposed to the outside world, breathing in not just oxygen but also dust, pollutants, bacteria, and ...

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

BioVaxys Technology Corp. ( BioVaxys) and Sona Nanotech Inc. ( Sona) have entered a Research Agreement to develop new cancer ...

CNW/ -- (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA) (OTC: SNANF) ("Sona") announce ...

A new research study suggests that a probiotic concoction could become a novel therapy to help lower the risk of Alzheimer’s ...